We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Prokarium Secures $10 Million for Clinical Development of Revolutionary Thermostable Vaccines

News   Feb 26, 2018 | Original story from Prokarium

 
Prokarium Secures $10 Million for Clinical Development of Revolutionary Thermostable Vaccines
 
 
 

RELATED ARTICLES

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

News

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

READ MORE

Personalized Implants Designed to Improve Organ Transplant Success

News

Host-derived scaffolding material may reduce the chance of organ transplant rejection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE